Frazier Life Sciences

Investment thesis

Invests in and builds product-focused biopharma companies with potential to generate meaningful clinical data or commercialize therapeutics. Venture strategy emphasizes early-stage private companies, company creation and Series A investments, with a meaningful share of the fund devoted to founding new companies.

Notable portfolio

Sector focus